The downregulation of ANXA2 stalls cells in the G1 phase or S-G2/M phase in gastric cancer (Sun et al., 2013) and glioblastoma multiforme (Maule et al., 2016), respectively. The gene discussed is ANXA2; the disease is gastric cancer.